Keros Therapeutics (KROS) Total Current Liabilities (2019 - 2026)
Keros Therapeutics' Total Current Liabilities was $12.15 million in Q2 2026, down 65.0% from $34.71 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Total Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Total Current Liabilities at Keros Therapeutics came in at $20.41 million, down 25.6% from FY2024.
- Total Current Liabilities shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
- In earlier years, Total Current Liabilities was $27.45 million in FY2024 (+12.6%), $24.37 million in FY2023 (+47.3%), $16.55 million in FY2022 (+39.7%) and $11.85 million in FY2021 (+64.9%).
- The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q3 2022.
- Compared with a year earlier, Total Current Liabilities was higher in four of the last seven quarters, with growth averaging 21.8%.
- The best year-over-year quarter for Total Current Liabilities over five years was Q1 2025 (growth of 110.4%); the worst was Q2 2026 (a decline of 65.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -31.27 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 15.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.86 Mn |
| Jun 30, 2026 | 12.15 Mn |
| Mar 31, 2026 | 12.85 Mn |
| Dec 31, 2025 | 20.41 Mn |
| Sep 30, 2025 | 24.09 Mn |
| Jun 30, 2025 | 34.71 Mn |
| Mar 31, 2025 | 39.38 Mn |
| Dec 31, 2024 | 27.45 Mn |
| Sep 30, 2024 | 29.01 Mn |
| Jun 30, 2024 | 21.25 Mn |
| Mar 31, 2024 | 18.72 Mn |
| Dec 31, 2023 | 24.37 Mn |
| Sep 30, 2023 | 16.70 Mn |
| Jun 30, 2023 | 16.10 Mn |
| Mar 31, 2023 | 15.46 Mn |
| Dec 31, 2022 | 16.55 Mn |
| Sep 30, 2022 | 11.53 Mn |
| Jun 30, 2022 | 15.45 Mn |
| Mar 31, 2022 | 11.65 Mn |
| Dec 31, 2021 | 11.85 Mn |
API Access
Keros Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();